$1.52
0.02 (+1.32%)
DUSA Pharmaceuticals, Inc. (DUSA)
CAPS Rating:
A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.

RSS Headlines
Fool UK